45,35 €*
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
- Preface
- Chapter 1. Virus Shaping History and Discovery of Virus
- 1.1 Virus shaping history
- 1.1.1 Tulipomania: bubbles of bulbs
- 1.1.2 The fall of old Mexico and Peru
- 1.1.3 Succession of thrones
- 1.1.4 The Louisiana Purchase
- 1.2 Discovery of virus
- 1.2.1 The gem theory
- 1.2.2 Discovery of virus
- 1.2.3 Cancer-causing viruses
- 1.2.4 Discovery of retrovirus
- Chapter 2. HIV/AIDS Drugs, Transforming a Death Sentence to a Chronic Disease
- 2.1 Discovery of the virus
- 2.1.1 A death sentence
- 2.1.2 Discovery of HIV and the great scientific controversy
- 2.1.3 The Nobel Prize
- 2.2 The first ray of hope
- 2.2.1 Nucleoside antiviral drugs
- 2.2.2 Non-nucleoside reverse transcriptase inhibitors
- 2.3 HIV protease inhibitors
- 2.3.1 HIV protease
- 2.3.2 First-generation HIV protease inhibitors
- 2.3.3 Second-generation HIV protease inhibitors
- 2.4 HIV integrase inhibitors
- 2.5 HIV Entry Inhibitors
- 2.5.1 HIV fusion inhibitors
- 2.5.2 CCR5 inhibitors
- 2.6 Triumph of modern medicine
- Chapter 3. Hepatitis Drugs
- 3.1 Hepatitis A virus
- 3.1.1 Discovery of hepatitis A virus
- 3.1.2 Hepatitis A vaccines
- 3.2 Hepatitis B virus
- 3.2.1 Discovery of hepatitis B virus
- 3.2.2 Hepatitis B vaccines
- 3.2.3 Hepatitis B drugs
- 3.3 Hepatitis C virus
- 3.3.1 Discovery of Hepatitis C virus
- 3.3.2 Hepatitis C virus NS3/4A protease inhibitors
- 3.3.3 Hepatitis C virus NS5A replication complex inhibitors
- 3.3.4 Hepatitis C virus NS5B polymerase inhibitors
- 3.4 Triumph of modern medicines
- Chapter 4. Influenza: A Perennial Killer
- 4.1 Influenza, a perennial killer
- 4.2 A virus that changed the world: the 1918 Spanish flu pandemic
- 4.3 Discovery of the influenza virus
- 4.4 Influenza vaccines
- 4.4.1 History of vaccination
- 4.4.2 History of influenza vaccines
- 4.4.3 Influenza vaccines today
- 4.5 Influenza drugs
- 4.5.1 M2 inhibitors
- 4.5.2 Influenza virus neuraminidase inhibitors
- 4.5.3 Cap-dependent endonuclease [...] inhibitor
- Chapter 5. Coronaviruses
- 5.1 Coronavirus Drugs
- 5.1.1. SARS
- 5.1.2. MARS
- 5.1.3. SARS-CoV-2
- 5.2 COVID-19 Vaccines
- 5.2.1. Pfizer/Biotech's mRNA vaccine
- 5.2.2. Johnson and Johnson's viral vector vaccine
- 5.3 COVID-19 Drugs
- 5.3.1. Remdesivir (Veklury)
- 5.3.2. Dexamethasone
- Chapter 6. Closing Remarks
- Bibliography
- Chemical Structures of Antiviral Drugs
| Erscheinungsjahr: | 2023 |
|---|---|
| Fachbereich: | Toxikologie |
| Genre: | Importe, Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Buch |
| Inhalt: | Gebunden |
| ISBN-13: | 9780197609859 |
| ISBN-10: | 0197609856 |
| Sprache: | Englisch |
| Einband: | Gebunden |
| Autor: | Li, Jie Jack |
| Hersteller: | Oxford University Press Inc |
| Verantwortliche Person für die EU: | Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de |
| Maße: | 229 x 151 x 24 mm |
| Von/Mit: | Jie Jack Li |
| Erscheinungsdatum: | 23.02.2023 |
| Gewicht: | 0,398 kg |
- Preface
- Chapter 1. Virus Shaping History and Discovery of Virus
- 1.1 Virus shaping history
- 1.1.1 Tulipomania: bubbles of bulbs
- 1.1.2 The fall of old Mexico and Peru
- 1.1.3 Succession of thrones
- 1.1.4 The Louisiana Purchase
- 1.2 Discovery of virus
- 1.2.1 The gem theory
- 1.2.2 Discovery of virus
- 1.2.3 Cancer-causing viruses
- 1.2.4 Discovery of retrovirus
- Chapter 2. HIV/AIDS Drugs, Transforming a Death Sentence to a Chronic Disease
- 2.1 Discovery of the virus
- 2.1.1 A death sentence
- 2.1.2 Discovery of HIV and the great scientific controversy
- 2.1.3 The Nobel Prize
- 2.2 The first ray of hope
- 2.2.1 Nucleoside antiviral drugs
- 2.2.2 Non-nucleoside reverse transcriptase inhibitors
- 2.3 HIV protease inhibitors
- 2.3.1 HIV protease
- 2.3.2 First-generation HIV protease inhibitors
- 2.3.3 Second-generation HIV protease inhibitors
- 2.4 HIV integrase inhibitors
- 2.5 HIV Entry Inhibitors
- 2.5.1 HIV fusion inhibitors
- 2.5.2 CCR5 inhibitors
- 2.6 Triumph of modern medicine
- Chapter 3. Hepatitis Drugs
- 3.1 Hepatitis A virus
- 3.1.1 Discovery of hepatitis A virus
- 3.1.2 Hepatitis A vaccines
- 3.2 Hepatitis B virus
- 3.2.1 Discovery of hepatitis B virus
- 3.2.2 Hepatitis B vaccines
- 3.2.3 Hepatitis B drugs
- 3.3 Hepatitis C virus
- 3.3.1 Discovery of Hepatitis C virus
- 3.3.2 Hepatitis C virus NS3/4A protease inhibitors
- 3.3.3 Hepatitis C virus NS5A replication complex inhibitors
- 3.3.4 Hepatitis C virus NS5B polymerase inhibitors
- 3.4 Triumph of modern medicines
- Chapter 4. Influenza: A Perennial Killer
- 4.1 Influenza, a perennial killer
- 4.2 A virus that changed the world: the 1918 Spanish flu pandemic
- 4.3 Discovery of the influenza virus
- 4.4 Influenza vaccines
- 4.4.1 History of vaccination
- 4.4.2 History of influenza vaccines
- 4.4.3 Influenza vaccines today
- 4.5 Influenza drugs
- 4.5.1 M2 inhibitors
- 4.5.2 Influenza virus neuraminidase inhibitors
- 4.5.3 Cap-dependent endonuclease [...] inhibitor
- Chapter 5. Coronaviruses
- 5.1 Coronavirus Drugs
- 5.1.1. SARS
- 5.1.2. MARS
- 5.1.3. SARS-CoV-2
- 5.2 COVID-19 Vaccines
- 5.2.1. Pfizer/Biotech's mRNA vaccine
- 5.2.2. Johnson and Johnson's viral vector vaccine
- 5.3 COVID-19 Drugs
- 5.3.1. Remdesivir (Veklury)
- 5.3.2. Dexamethasone
- Chapter 6. Closing Remarks
- Bibliography
- Chemical Structures of Antiviral Drugs
| Erscheinungsjahr: | 2023 |
|---|---|
| Fachbereich: | Toxikologie |
| Genre: | Importe, Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Buch |
| Inhalt: | Gebunden |
| ISBN-13: | 9780197609859 |
| ISBN-10: | 0197609856 |
| Sprache: | Englisch |
| Einband: | Gebunden |
| Autor: | Li, Jie Jack |
| Hersteller: | Oxford University Press Inc |
| Verantwortliche Person für die EU: | Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de |
| Maße: | 229 x 151 x 24 mm |
| Von/Mit: | Jie Jack Li |
| Erscheinungsdatum: | 23.02.2023 |
| Gewicht: | 0,398 kg |
Ähnliche Produkte
Lieferzeit 1-2 Wochen
Lieferzeit 1-2 Wochen
Lieferzeit 1-2 Wochen
Lieferzeit 2-4 Werktage
Lieferzeit 2-4 Werktage
Lieferzeit 1-2 Wochen
Lieferzeit 1-2 Wochen
Lieferzeit 4-7 Werktage
